Showing results (301-310 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|June 21, 2018
The cost of dysphagia in geriatric patientsSigne Westmark, Dorte Melgaard, Line O Rethmeier, et al.Clinicoeconomics and Outcomes Research : CEOR|March 10, 2015
Health services financing and delivery: analysis of policy options for Dubai, United Arab EmiratesSamer HamidiClinicoeconomics and Outcomes Research : CEOR|August 6, 2020
Future Development Through the Past: Pathology of the Financing Dimension of Iran's Health Transformation PlanLeila Doshmangir, Behzad Najafi, Hakimeh Mostafavi, et al.Clinicoeconomics and Outcomes Research : CEOR|March 12, 2015
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer dataTyler Knight, Caroline Schaefer, Holly Krasa, et al.Clinicoeconomics and Outcomes Research : CEOR|February 25, 2015
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in SpainJosep Darbà, Lisette Kaskens, Francesc Sorio Vilela, et al.Clinicoeconomics and Outcomes Research : CEOR|May 5, 2023
Projected Savings Associated with Lowering the Risk of Total Hip Arthroplasty Revision Due to Dislocation in Patients with Spinopelvic PathologyStacey J Ackerman, Jonathan M Vigdorchik, Breana R Siljander, et al.Clinicoeconomics and Outcomes Research : CEOR|April 17, 2015
Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United KingdomSeye Abogunrin, Linda Hortobagyi, Edit Remak, et al.Clinicoeconomics and Outcomes Research : CEOR|July 2, 2020
Disparities in Emergency Transport of Women with a Preterm Labor Diagnosis in Urban vs Rural Areas in the USAdrian Vilalta, Kathleen A TroegerClinicoeconomics and Outcomes Research : CEOR|May 26, 2012
Economic evaluation of intravenous iron treatments in the management of anemia patients in GreeceVassilis Fragoulakis, Georgia Kourlaba, Dimitris Goumenos, et al.Clinicoeconomics and Outcomes Research : CEOR|May 10, 2012
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsGraham F Pineo, Jay Lin, Lieven AnnemansPageof 102